PAREXEL TO PRESENT LEADING INSIGHTS REGARDING KEY INDUSTRY TOPICS AT 20TH ANNUAL DIA EUROMEETING
BOSTON, MA, February 25, 2008 – Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global bio/pharmaceutical services provider, will present on key topics at the Drug Information Association’s (DIA) 20th Annual EuroMeeting in Barcelona, Spain being held March 3 – 5, 2008. Attendees will benefit from presentations by some of PAREXEL’s thought leaders, selected by the DIA to address industry issues including pharmacovigilance, globalization of clinical trials, data-driven patient recruitment, non-interventional studies, gene therapy regulations, combination products, biosimilars, and cosmeceuticals.
For more than 25 years, clients have relied on PAREXEL to provide integrated clinical development, regulatory affairs consulting, and commercialization services, as well as to offer technologies that expedite time-to-market. Attendees at the DIA EuroMeeting can visit PAREXEL’s Booth 179 in the exhibit hall to discuss these areas or to view a demonstration of the industry-leading Clinical Trial Management System IMPACT® software, provided by PAREXEL’s subsidiary, Perceptive Informatics.
DIA’s 20th Annual EuroMeeting is global in scope, attracting more than 3,000 attendees. This meeting brings together professionals from the biopharmaceutical industry, contract service organizations, academic research centers, and regulatory agencies. With more than 100 sessions and 11 themes, and more than 350 speakers, the annual event covers a variety of cross-disciplinary topics.
For more information about PAREXEL visit www.PAREXEL.com or Booth 179 at the DIA EuroMeeting.
# # #